+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

bioLytical Laboratories Inc - Product Pipeline Analysis, 2019 Update

  • ID: 4455913
  • Company Profile
  • December 2019
  • Region: Global
  • 29 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abt Associates Inc
  • Affinity Biologicals Inc
  • Amico Corp
  • Maxim Biomedical Inc
  • MORE
Summary

bioLytical Laboratories Inc (bioLytical) operates as a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that translates into a value proposition. bioLytical provides insti kit which is a rapid antibody test, that detects antibodies of human immunodeficiency virus type one and type two in human whole blood, fingerstick blood, serum and plasma, among others. The company caters tests for diseases such as hepatitis C, Ebola, R and D programs, patients, healthcare professionals, payers, public health organizations, and others. It provides customer care services and markets its products through distributors in Canada and India. bioLytical is headquartered in Richmond, British Columbia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company bioLytical Laboratories Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abt Associates Inc
  • Affinity Biologicals Inc
  • Amico Corp
  • Maxim Biomedical Inc
  • MORE
  • bioLytical Laboratories Inc Company Overview
  • bioLytical Laboratories Inc Company Snapshot
  • bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
  • bioLytical Laboratories Inc - Pipeline Analysis Overview
  • bioLytical Laboratories Inc - Key Facts
  • bioLytical Laboratories Inc - Major Products and Services
  • bioLytical Laboratories Inc Pipeline Products by Development Stage
  • bioLytical Laboratories Inc Pipeline Products Overview
  • INSTI Ebola Test
  • INSTI Ebola Test Product Overview
  • INSTI HIV Self Test
  • INSTI HIV Self Test Product Overview
  • INSTI Test - Chikungunya
  • INSTI Test - Chikungunya Product Overview
  • INSTI Test - Dengue
  • INSTI Test - Dengue Product Overview
  • INSTI Test - Hepatitis C
  • INSTI Test - Hepatitis C Product Overview
  • Zika/Flavivirus Test
  • Zika/Flavivirus Test Product Overview
  • bioLytical Laboratories Inc - Key Competitors
  • bioLytical Laboratories Inc - Key Employees
  • bioLytical Laboratories Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • bioLytical Laboratories Inc, Recent Developments
  • Sep 19, 2019: INSTI now available for expanded point-of-care use in Canada
  • Aug 08, 2019: HIV Self-testing Trial Begins in Canada
  • Feb 21, 2019: bioLytical Laboratories earns MDSAP certification, highest quality standard in medical device industry
  • Nov 28, 2018: INSTI HIV Self Test earns WHO prequalification status for home testing
  • Nov 24, 2017: VANC Pharmaceuticals Plans to Launch INSTI HIV Test with United Pharma Group on World AIDS Day
  • Jul 28, 2017: INSTI HIV Self Test detects HIV two weeks sooner than other brands
  • Jul 28, 2017: Instant HIV home test launched in the Netherlands
  • Jul 27, 2017: INSTI HIV Self Test Demonstrates High User Acceptance in Kenya Study
  • Jul 06, 2017: INSTI HIV Self Test Receives Global Fund Classification for Procurement
  • May 17, 2017: VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test
  • Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
  • bioLytical Laboratories Inc Pipeline Products by Equipment Type
  • bioLytical Laboratories Inc Pipeline Products by Indication
  • bioLytical Laboratories Inc, Key Facts
  • bioLytical Laboratories Inc, Major Products and Services
  • bioLytical Laboratories Inc Number of Pipeline Products by Development Stage
  • bioLytical Laboratories Inc Pipeline Products Summary by Development Stage
  • INSTI Ebola Test - Product Status
  • INSTI Ebola Test - Product Description
  • INSTI HIV Self Test - Product Status
  • INSTI HIV Self Test - Product Description
  • INSTI Test - Chikungunya - Product Status
  • INSTI Test - Chikungunya - Product Description
  • INSTI Test - Dengue - Product Status
  • INSTI Test - Dengue - Product Description
  • INSTI Test - Hepatitis C - Product Status
  • INSTI Test - Hepatitis C - Product Description
  • Zika/Flavivirus Test - Product Status
  • Zika/Flavivirus Test - Product Description
  • bioLytical Laboratories Inc, Key Employees
  • bioLytical Laboratories Inc, Other Locations
  • Glossary
List of Figures
  • bioLytical Laboratories Inc Pipeline Products by Equipment Type
  • bioLytical Laboratories Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Qualyst Transporter Solutions LLC
  • Maxim Biomedical Inc
  • Home Health Care Management Inc
  • Amplyx Pharmaceuticals Inc
  • Amico Corp
  • Alethia Biotherapeutics Inc
  • Affinity Biologicals Inc
  • Abt Associates Inc
Note: Product cover images may vary from those shown
Adroll
adroll